Key facts
- Zero Infinity Partners is a venture capital firm based in New York, New York with 24 tracked portfolio companies.
- Notable positions include FluidStack, HavocAI, EnCharge AI, Bluestem Biosciences, Aira Technologies.
About Zero Infinity Partners
Founded in 2022, Zero Infinity Partners is a venture capital firm based in New York, New York. The firm invests in founders and companies looking to deploy innovative technologies and business ideas in the global infrastructure sectors, including energy, power, mobility, logistics, data, water, and waste. The firm offers the vision, discipline, and deep infra ecosystem understanding essential to futureproofing and advancing the systems that keep the world in motion - through the following innovations: digitisation & automation, decarbonization & electrification, and differentiated project development.
Free account
See the whole book
- ·The book's top 25 — of 24 recorded positions
- ·Watchlist + alerts for Zero Infinity Partners's activity
Create free account
No card required
Portfolio, priced
24 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| FluidStack | Business/Productivity Software | $7.5B | — | |
| HavocAI | — | $784.0M | — | |
| EnCharge AI | — | $430.0M | — | |
| Bluestem Biosciences | — | $135.0M | — | |
| Aira Technologies | — | $90.0M | — | |
| Synonym (Consulting Services (B2B)) | — | $83.5M | — | |
| GlacierGrid | — | $71.3M | — | |
| Branch Energy | — | $38.8M | — | |
| GreenSpark Software | — | $26.0M | — | |
| CloudForge | — | $13.0M | — | |
| Humoniq | — | $7.1M | — | |
| Somos Internet | — | $1.8M | — | |
| Opfyx | — | — | — | |
| Persona AI (Houston) | — | — | — | |
| Rebar (Business/Productivity Software) | — | — | — | |
| + 9 more companies · a free account shows the top of the book | ||||
Frequently asked
- What companies does Zero Infinity Partners invest in?
- Zero Infinity Partners has 24 recorded portfolio companies, including FluidStack, HavocAI, EnCharge AI, Bluestem Biosciences.